Suramin inhibits glioma cell proliferationin vitro and in the brain
- 1 January 1994
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 21 (3) , 189-201
- https://doi.org/10.1007/bf01063768
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Suramin in advanced platinum-resistant ovarian cancerEuropean Journal Of Cancer, 1992
- Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicityCancer Letters, 1991
- Inhibition of Angiogenesis with Combination Treatments of Angiostatic Steroids and SuraminInternational Journal of Radiation Biology, 1991
- Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growthJournal of Neuroscience Research, 1990
- Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Antiproliferative effects of suramin on androgen responsive tumour cellsEuropean Journal of Cancer and Clinical Oncology, 1990
- Suramin inhibits proliferation of rat glioma cells and alters N-cam cell surface expressionInternational Journal of Cancer, 1990
- Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.Journal of Histochemistry & Cytochemistry, 1989
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985